Drawing for ISOFOL MEDICAL

USPTO serial 79337849

ISOFOL MEDICAL

Reviewed by CopyMark Law Group

Reg. 7416108Status 700Registered
Filing date
Status date
Registration date
Jun 18, 2024
Examiner
PINO, DOMINIC ROBERT
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ISOFOL MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica S. Sachs

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098

Goods and services

ClassDescriptionStatusFirst use
042Medical, pharmaceutical and biological research services; conducting scientific projects in the nature of clinical studies or clinical trials of patients and scientific laboratory services in the fields of medicine, pharmaceuticals and biology; development and testing of pharmaceutical preparations and medicines; research and development in the fields of pharmaceutical preparations, biology, and for treatment of cancerACTIVE—
044Medical and pharmaceutical consultancy relating to scientific projects in the nature of clinical studies or clinical trials of patients in the fields of medicine, pharmaceuticals and biology; Medical analysis services relating to the pharmaceutical treatment of personsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 14, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 23, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 23, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 18, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 18, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 18, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 8, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 20, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 20, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 20, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 30, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 13, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 13, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 7, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 4, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 4, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 13, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 12, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2022DOCKASSIGNED TO EXAMINER—
Apr 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance